A new guideline, the 2024 Updated ACR Guideline for the Diagnosis and Treatment of Lupus Nephritis, is being introduced at ACR Convergence 2024 on Monday, Nov. 18.
In the session, Lisa Sammaritano, MD, professor of clinical medicine at Weill Cornell Medicine and Hospital for Special Surgery, New York, will discuss the guideline development process and key recommendations.
Maria Dall’Era, MD, the Jean S. Engleman Professor and chief of rheumatology, director of the Rheumatology Clinical Research Center, clinical researcher and practicing rheumatologist at the University of California, San Francisco, will discuss how to apply the updated guideline to various classes of lupus nephritis.
Anca Askanase, MD, MPH, an academic rheumatologist at Columbia University Medical Center, New York, will specifically address how to apply the guideline to membranous lupus nephritis, and Mary Beth Son, MD, Boston Children’s Hospital, Brookline, Mass., will talk about its application to pediatric lupus nephritis.
Watch this space for a report on this first look at the proposed recommendations following the meeting.
